BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Net income as a percentage of revenue
Latest
30.16%
↑ 112% vs avg
Percentile
P100
Near historical high
Streak
5 yr
Consecutive growthExpanding
Average
-247.63%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | 30.16% | +252.9% |
| 2024 | -19.72% | +71.2% |
| 2023 | -68.36% | +25.1% |
| 2022 | -91.24% | +22.1% |
| 2021 | -117.11% | +88.6% |
| 2020 | -1026.35% | -360.3% |
| 2019 | -222.99% | +54.5% |
| 2018 | -490.25% | -87.7% |
| 2017 | -261.18% | -24.8% |
| 2016 | -209.25% | - |